Boston Scientific Ventures invests in companies developing innovative medical solutions that improve outcomes, increase efficiencies, and serve patients connected to their businesses. Since 2012, they have invested over $1 billion in more than 70 portfolio companies, with over 40 active portfolio companies ranging from early-stage R&D to commercialization. They are a strategic investor and have frequently acquired companies from their venture portfolio.
Is Boston Scientific Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Boston Scientific Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A, Series B or later
First ticket size
US$2,500,000 - US$96,000,000
When approaching Boston Scientific Ventures, founders should highlight how their technology or solution can strategically complement or extend Boston Scientific’s existing product lines or address unmet clinical needs in their core therapeutic areas. Demonstrating a clear path to clinical validation, regulatory milestones, and eventual market adoption will resonate, especially if your solution can integrate with or enhance current standards of care. Emphasize your team's domain expertise and your understanding of the healthcare ecosystem, as Boston Scientific values partners who can navigate complex clinical and commercial landscapes.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.